Indivior Pharmaceuticals, Inc. INDV Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's investing cash flow?
- Indivior Pharmaceuticals, Inc. (INDV) reported investing cash flow of -$19M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's investing cash flow changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's investing cash flow decreased by 280.0% year-over-year, from -$5M to -$19M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's investing cash flow?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's investing cash flow has grown at a -33.3% compound annual growth rate (CAGR), from -$222M to -$66M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.